Arrowhead Pharmaceuticals Inc
ARWR
NASDAQ
Biotechnology
$86.64
USD
+1.05 (+1.23%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $12.21B
Volume 817.8K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma Inc | $15.84B | - | +355.2% | - | |
NBIX | Neurocrine Biosciences Inc | $15.51B | 21.99 | +34.4% | - | |
BMRN | BioMarin Pharmaceutical Inc | $13.35B | 182.98 | +11.2% | - | |
EXEL | Exelixis Inc | $12.52B | 14.54 | +9.2% | - | |
ARWR | Arrowhead Pharmaceuticals Inc | $12.21B | - | +16.9% | - | |
MDGL | Madrigal Pharmaceuticals Inc | $11.73B | - | +149.0% | - | |
HALO | Halozyme Therapeutics Inc | $11.43B | 27.63 | +41.1% | - | |
SMMT | Summit Therapeutics Inc | $11.34B | - | - | - | |
CYTK | Cytokinetics Inc | $10.36B | - | -21.1% | - | |
PRAX | Praxis Precision Medicines Inc | $10.29B | - | - | - |
Top Peer by Growth
BridgeBio Pharma Inc
+355.2% YoY Revenue
Lowest P/E Ratio
Exelixis Inc
14.54x P/E
Best 1-Year Return
Praxis Precision Medicines Inc
+697.2% Return